Search
Aptevo Therapeutics Inc
APVOAdd to Watchlist
4.110USD
-0.020-0.48%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.10MMarket Cap
0.00P/E TTM
APVO Financials
See Aptevo Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Aptevo Therapeutics Inc Earnings Date
Latest Release
May 13, 2026
EPS / Forecast
-6.41/-5.60
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-87.27
99.99%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its current assets were 23.08M, with a year-on-year change of 116.54.
What are the total assets of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its total assets of Aptevo Therapeutics Inc were 27.19M, with a year-on-year change of 74.42.
What are the total liabilities of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its total liabilities of Aptevo Therapeutics Inc were 9.81M, with a year-on-year change of -9.44.
What is the total equity of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its total equity of Aptevo Therapeutics Inc was 17.38M, with a year-on-year change of 265.53.
What is the net operating income of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its net operating income of Aptevo Therapeutics Inc was -26.31M, with a year-on-year change of -6.95.
What is the net financing of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its net financing of Aptevo Therapeutics Inc was 38.50M, with a year-on-year change of 146.85.
What is the Earnings Per Share (EPS) of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -87.27, with a year-on-year change of 99.99.
What is the net income of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its net income was -27.54M, with a year-on-year change of -14.12.
What is the Return on Equity (ROE) of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -248.81, with a year-on-year change of 12.48.
What is the Return on Assets (ROA) of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -121.38, with a year-on-year change of -1.70.
What is the operating profit of Aptevo Therapeutics Inc?
According to Aptevo Therapeutics Inc's FY2025 earnings report, its operating profit was -26.31M, with a year-on-year change of -6.95.